Viewing Study NCT05761132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2026-01-29 @ 10:33 AM
Study NCT ID: NCT05761132
Status: UNKNOWN
Last Update Posted: 2023-03-09
First Post: 2022-08-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study
Sponsor: Leiden University Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Vulva Cancer View
None Vulva Neoplasm View
None Squamous Cell Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pembrolizumab View
None immunotherapy View
None neoadjuvant View